Refine by
Spike Protein Equipment & Supplies
52 equipment items found
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
The beta variant — initially found in South Africa — showed additional mutations in the spike protein, the most important ones as K417N, E484K and N501Y (the last one was found already in the Beta variant). Also, the early mentioned D614G mutation remained in this variant. ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
The Alpha variant, also known as B.1.1.7., was emerging as a VOCs after a mutation in the spike protein D614G, was recognized as possibly affecting the infectivity in people in an enhanced way. The Alpha variant carried this mutation and others, for example, N501Y, and was considered 40-80% more transmissible than the original “Wuhan” ...
Manufactured by:Genscript based inPiscataway, NEW JERSEY (USA)
SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. The spike protein mutation N501Y is one of six key contact residues within the receptor-binding domain (RBD) and has been identified as increasing binding affinity to human ...
Manufactured by:Immunodiagnostic Systems Holdings PLC based inBoldon Colliery, UNITED KINGDOM
The Spike Protein Inhibition Assay (SPIA) is a competitive immunoenzymatic colorimetric method used for research purposes only to detect neutralising antibodies against SARS-CoV-2 in human ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
We've created a stable, clonally derived, recombinant, suspension grown CHO cell line that produces a secreted, stabilized version of the trimeric spike protein of ...
Manufactured by:RayBiotech Life, Inc. based inPeachtree Corners, GEORGIA (US) (USA)
The SARS-CoV-2 Spike Protein Overlapping Peptide Array is semi-quantitative array displaying 316 synthesized peptides representing the full-length SARS-CoV-2 Spike protein (wild-type). It is suitable for antibody epitope mapping and detection of IgG, IgM, or IgA in serum, plasma, and other liquid sample types. ...
Manufactured by:Phoenix Pharmaceuticals, Inc. based inBurlingame, CALIFORNIA (USA)
Molecular Weight: 5752.52, Purity: ≥ 90%, Validation: Exhibits correct molecular weight, Storage: Up to 6 months in lyophilized form at 0-5ºC. For best results, rehydrate just before use. After rehydration, keep solution at +4ºC for up to 5 days or freeze at -20ºC for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles. Appearance: White powder, ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
It contains again the 614G mutations and others, notably a proline to arginine substitution that may facilitate the cleavage of the S precursor into the S1/S2 conversion, which results in the fusion of the spike protein with the cell membrane receptor ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
The SARS-CoV-2 Omicron variant became known to the general public recently (end of November 2021) and is characterized by many mutations in the Spike protein and other regions of the virus genome. It seems to spread even more rapidly than the Delta variant, and questions about the protection against this variant by presently used vaccines have been raised. This ...
Manufactured by:Wuhan Fine Biotech Co., Ltd. based inWuhan, CHINA
COVID-19 Spike Protein Accquant ELISA Kit allows for the in vitro quantitative determination of COVID-19 Sipke ELISA Kit concentrations in serum, plasma, tissue homogenates and other biological fluids. ...
Manufactured by:Leadgene Biomedical Inc. based inTainan City, TAIWAN
Keep ampoules at -20°C or -80°C for storage. No needs to spin the ampoule before opening. Remove the cap carefully. Dissolve the lyophilized protein by adding sterile ddH2O along the inner side of ampoule to avoid generating bubbles. Make protein concentration to be at 100 μg/mL, or consult product’s Certificate of Analysis (CoA). (Note: No needs to add carriers* to the initial ...
Manufactured by:Prima Lab SA based inBalerna, SWITZERLAND
COVID-19 Neutralising IgG Serological Test is a rapid device which verifies the presence of COVID-19 neutralising IgG antibodies in human blood samples produced after the end of the vaccination cycle. ...
Manufactured by:ExcellGene SA based inMonthey, SWITZERLAND
In addition to stabilized trimeric spike proteins, we also offer the RBD domain produced in the same CHO cell system. The RBD protein is easier to produce and to purify and is therefore an ideal alternative for applications where costs are the driving factor. Please contact us to learn about our pricing per gram or mg of RBD ...
Manufactured by:Leadgene Biomedical Inc. based inTainan City, TAIWAN
SARS-CoV-2 virus-like particles B1.351 (Beta) are composed of four structural proteins: Membrane protein (M), Nucleocapsid protein (N), Beta-spike protein (S) and Envelope protein (E). VLPs are produced in mammalian HEK293 cells. ...
Manufactured by:Leadgene Biomedical Inc. based inTainan City, TAIWAN
The neutralizing antibody blocks the interaction between RBD and ACE2. The uncut sheet must be further cut into individual strips. (Test line: spike ...
Manufactured by:Virometix AG based inSchlieren, SWITZERLAND
Our epitope-focused SVLP-based vaccine aims to target specific regions of the Receptor Binding Domain (RBD) of the Spike protein. Proof-of-concept studies are currently ongoing using SARS-CoV-2, where five Synthetic Antigen Mimetics (SAM) were rapidly designed and synthesized for an optimal neutralization ...
Manufactured by:Accel Diagnostics based inHouston, TEXAS (USA)
A Rapid Test for the Quantitation of the Titer of Antibody Against the Spike Protein of the SARS-COV-2 VIRUS. Accel Diagnostics’ rapid quantitative COVID-19 serology assay for the detection and qualification anti-Spike SARS-COV-2 antibody concentration (IgG) is now ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
In 2012, within weeks of obtaining the sequence of the circulating MERS strain, we successfully produced a vaccine candidate. Our MERS candidate was based on the major surface spike protein, which we had previously identified as the antigen of choice in our work with our SARS vaccine candidate. In 2014, in collaboration with the University of Maryland School of ...
Manufactured by:Novavax based inGaithersburg, MARYLAND (USA)
In 2012, within weeks of obtaining the sequence of the circulating MERS strain, we successfully produced a vaccine candidate. Our MERS candidate was based on the major surface spike protein, which we had previously identified as the antigen of choice in our work with our SARS vaccine candidate. In 2014, in collaboration with the University of Maryland School of ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-1850 is the planned new version of the TNX-1800 vaccine that encodes spike protein from SARS-CoV-2 BA.2 ...